+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) - Forecast to 2028

  • PDF Icon

    Report

  • 211 Pages
  • June 2023
  • Region: Global
  • Markets and Markets
  • ID: 5850039

High Cost of In-House IVD Manufacturing

The global IVD contract manufacturing market is projected to reach USD 25.5 billion by 2028 from USD 15.0 billion in 2023, at a CAGR of 11.2% during the forecast period. The high cost associated with in-house manufactured IVD products, the adoption of new technology to develop efficient products by IVD contract manufacturers, and the increased need to outsource manufacturing to CMOs by large manufacturers to reduce the manufacturing burden and focus on the development of newer technology.  

There have been increased manufacturing activities and development by CMOs of advanced technological equipment to compete in this highly fragmented market and strengthen its position. 

IVD Equipment segment accounted for a larger share of the IVD contract manufacturing market

In 2022, the IVD equipment segment accounted for a larger share of the IVD contract manufacturing market. This segment is also estimated to grow at a stable CAGR during the forecast period. Growth in this segment can primarily be attributed to the increasing volume of IVD tests performed globally and the need burst of molecular test equipment post the Covid-19 pandemic.

The molecular diagnostic segment will grow at highest CAGR during the forecast period

Based on technology, the molecular diagnostic segment will grow at the highest CAGR during the forecast period.  Growth in this segment can primarily be attributed to the rising prevalence of infectious diseases, cancer, and various genetic disorders, increasing applications of molecular diagnostic technologies in pharmacogenetics and point-of-care testing. Moreover, the increasing awareness and acceptance of personalized medicine, technological advancements, and the growing application of MDx in hereditary disease testing & prenatal testing are also likely to influence the market growth. The growing use of PCR in proteomics and genomics, automation of instruments, and the emergence of advanced technologies such as qRT-PCR are also likely to support the growth of the market

Asia Pacific will grow at highest CAGR during the forecast period

In 2022, Asia Pacific will grow at the highest CAGR during the forecast period. Major factors driving the growth of this market are the presence of a large number of contract manufacturers, the rise in the number of CMOs in China and India at an exorbitantly high rate, the manufacturing capabilities and efficiency of the development plants in this region, ease of supply chain logistics, and cost-controlled production of high quality equipment.

The break-up of the profile of primary participants in the IVD contract manufacturing market: 

  • By Company Type: Tier 1 - 34%, Tier 2 - 38%, and Tier 3 - 28% 
  • By Designation: C Level - 26%, Director Level - 35%, Others-39% 
  • By Region: Asia Pacific - 39%, North America - 28%, Europe -17%, Latin America - 9% Middle East - 7%

The prominent players in the IVD contract manufacturing market include Jabil Inc. (US), Sanmina Corporation (US), TE Connectivity (Switzerland), Celestica Inc.(Canada), Savyon Diagnostics (Israel), West Pharmaceutical Services, Inc.(US), and Thermofisher (US).

Research Coverage:
The report analyzes the IVD contract manufacturing market and aims to estimate the market size and future growth potential of this market based on various segments such as device type, technology, service and region. The report also includes a product portfolio matrix of various IVD contract manufactured equipment or consumables available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies. 

Reasons to Buy the Report 
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall IVD contract manufacturing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. 

This report provides insights into the following pointers:

  • Analysis of key drivers (high cost effective manufacturing of high technological and patented technology), restraints (risk to OEMs intellectual property and quality control), opportunities (high growth in developing countries), and challenges (shortage of skilled labour) influencing the growth of the IVD contract manufacturing market 
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the IVD contract manufacturing market 
  • Market Development: Comprehensive information on the lucrative emerging markets by type, application, end user and region.
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global IVD contract manufacturing market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players like Jabil Inc. (US), Sanmina Corporation (US), TE Connectivity (Switzerland), Celestica Inc.(Canada), Savyon Diagnostics (Israel), Thermofisher (US) in the global IVD contract manufacturing market. 

Table of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.2.1 Inclusions and Exclusions
1.3 Market Scope
1.3.1 Markets Covered
Figure 1 Ivd Contract Manufacturing Market Segmentation
Figure 2 Ivd Contract Manufacturing Market: Regional Segmentation
1.3.2 Years Considered
1.3.3 Currency Considered
Table 1 Standard Currency Conversion Rates (Unit of USD)
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Research Data
Figure 3 Research Design
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
Figure 4 Primary Sources
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
Figure 5 Breakdown of Primary Interviews: Supply Side and Demand Side Participants
Figure 6 Breakdown of Primary Interviews (Supply Side): by Company Type, Designation, and Region
Figure 7 Breakdown of Primary Interviews (Demand Side): by End-user, Designation, and Region
2.2 Market Size Estimation
Figure 8 Supply-Side Market Size Estimation: Revenue Share Analysis
Figure 9 Revenue Share Analysis Illustration: Jabil Inc.
Figure 10 Supply-Side Analysis: Ivd Contract Manufacturing Market (2022)
Figure 11 Demand-Side Estimation for Ivd Contract Manufacturing Market
Figure 12 CAGR Projections from Analysis of Drivers, Restraints, Opportunities, and Challenges (2023-2028)
Figure 13 CAGR Projections: Supply-Side Analysis
2.2.1 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
Figure 14 Market Data Triangulation Methodology
2.4 Market Share Estimation
2.5 Study Assumptions
2.6 Limitations & Risk Assessment
2.6.1 Methodology-Related Limitations
2.6.2 Scope-Related Limitations
2.6.3 Risk Assessment
Table 2 Risk Assessment: Ivd Contract Manufacturing Market
2.7 Recession Impact Analysis

3 Executive Summary
Figure 15 Ivd Contract Manufacturing Market, by Product Type, 2023 vs. 2028 (USD Million)
Figure 16 Ivd Contract Manufacturing Market, by Service Type, 2023 vs. 2028 (USD Million)
Figure 17 Ivd Contract Manufacturing Market, by Technology, 2023 vs. 2028 (USD Million)
Figure 18 Ivd Contract Manufacturing Market: Geographical Snapshot, 2022

4 Premium Insights
4.1 Ivd Contract Manufacturing Market Overview
Figure 19 Technological Advancements in Ivd to Drive Market
4.2 Ivd Contract Manufacturing Market: Developed vs. Developing Markets
Figure 20 China to Register Highest Growth Rate During Forecast Period
4.3 Ivd Contract Manufacturing Market: Geographic Growth Opportunities
Figure 21 Asia-Pacific to Register Highest Growth Rate During Forecast Period
4.4 Ivd Contract Manufacturing Market: Regional Mix
Figure 22 Asia-Pacific to Dominate Market in 2028

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 23 Market Dynamics: Ivd Contract Manufacturing Market
Table 3 Market Dynamics: Impact Analysis
5.2.1 Drivers
5.2.1.1 Growing Outsourcing Activity by Ivd Manufacturers
5.2.1.2 High Cost of In-House Ivd Manufacturing
5.2.2 Restraints
5.2.2.1 IP Protection Concerns and Possibility of Theft
5.2.3 Opportunities
5.2.3.1 Growth Potential of Emerging Economies
Figure 24 Asia-Pacific: Healthcare Expenditure, 2010-2020 (% of GDP)
5.2.4 Challenges
5.2.4.1 Lack of Skilled Labor
5.3 Industry Trends
5.3.1 Automation of Clinical Laboratory Techniques
5.3.2 Microfluidics-based Poc and Lab-On-A-Chip Diagnostic Devices for Laboratory Testing
5.4 Porter's Five Forces Analysis
Figure 25 Ivd Contract Manufacturing Market: Porter's Five Forces Analysis
Table 4 Ivd Contract Manufacturing Market: Porter's Five Forces Analysis
5.4.1 Threat of Substitutes
5.4.2 Bargaining Power of Suppliers
5.4.3 Intensity of Competitive Rivalry
5.4.4 Bargaining Power of Buyers
5.4.5 Threat of New Entrants
5.5 Tariff and Regulatory Landscape
5.5.1 Regulatory Analysis
5.5.1.1 North America
5.5.1.1.1 US
Table 5 US: Classification of Medical Equipment
Table 6 US: Time, Cost, and Complexity of Registration Process
5.5.1.1.2 Canada
Table 7 Canada: Risk, Time, Cost, and Complexity of Registration Process
5.5.1.2 Europe
Table 8 Europe: Risk, Time, Cost, and Complexity of Registration Process
Figure 26 Europe: Ivdr Timeline
5.5.1.3 Asia-Pacific
5.5.1.3.1 Japan
Figure 27 Regulatory Process for Ivd Devices in Japan
Table 9 Japan: Classification of Ivd Reagents in Japan
Table 10 Japan: Time, Cost, and Complexity of Registration Process
5.5.1.3.2 China
Table 11 China: Time, Cost, and Complexity of Registration Process
5.5.1.3.3 India
Figure 28 India: Regulatory Process for Ivd Devices
5.5.1.4 South Korea
Table 12 South Korea: Time, Cost, and Complexity of Registration Process
5.5.2 Regulatory Bodies, Government Agencies, and Other Organizations
Table 13 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 14 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 15 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 16 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 17 Middle East & Africa: Regulatory Bodies, Government Agencies, and Other Organizations
5.6 Key Conferences and Events in 2022-2023
Table 18 Ivd Contract Manufacturing Market: Detailed List of Conferences and Events
5.7 Patent Analysis
5.7.1 Patent Publication Trends for Ivd Devices
Figure 29 Patent Publication Trends (January 2013-July 2023)
5.7.2 Insights: Jurisdiction and Top Applicant Analysis
Figure 30 Top Applicants and Owners (Companies/Institutes) for Ivd Devices Patents (January 2013-July 2023)
Figure 31 Top 10 Applicant Countries/Regions for Ivd Devices Patents (January 2013-July 2023)
5.7.3 Patent Publication Trends for Ivd Devices
Table 19 Ivd Devices: List of Major Patents
5.8 Technology Analysis
5.8.1 Key Technologies: Ivd Contract Manufacturing Market
5.8.2 Adjacent Technologies
5.9 Supply Chain Analysis
Figure 32 Ivd Contract Manufacturing Market: Supply Chain (2022)
5.10 Key Stakeholders and Buying Criteria
5.10.1 Key Stakeholders in Buying Process
Figure 33 Influence of Stakeholders on Buying Process of Ivd Products
5.10.2 Buying Criteria
Figure 34 Key Buying Criteria for Ivd Products
Table 20 Key Buying Criteria for Ivd Products
5.11 Ecosystem Analysis
Figure 35 Ivd Contract Manufacturing Market: Ecosystem Analysis (2022)
5.12 Revenue Sources to Shift Toward Technology-based Solutions
Figure 36 Revenue Sources to Shift Toward Technology-based Solutions
5.13 Ivd Contract Manufacturing Market: Recession Impact

6 Ivd Contract Manufacturing Market, by Product Typ
e
6.1 Introduction
Table 21 Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
6.2 Consumables
6.2.1 Consumables to Dominate Ivd Contract Manufacturing Market
Table 22 Ivd Contract Manufacturing Market for Consumables, by Country, 2021-2028 (USD Million)
6.3 Equipment
6.3.1 Automation, Advancements, and Emphasis on Efficient Diagnostics to Drive Market
Table 23 Ivd Contract Manufacturing Market for Equipment, by Country, 2021-2028 (USD Million)

7 Ivd Contract Manufacturing Market, by Technology
7.1 Introduction
Table 24 Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
7.2 Immunoassays
7.3 Rising Prevalence of Cancer to Drive Growth
Table 25 Ivd Contract Manufacturing Market for Immunoassays, by Country, 2021-2028 (USD Million)
7.4 Clinical Chemistry
7.4.1 Growing Incidence of Lifestyle Diseases to Drive Demand for Clinical Chemistry Assay Testing
Table 26 Ivd Contract Manufacturing Market for Clinical Chemistry, by Country, 2021-2028 (USD Million)
7.5 Molecular Diagnostics
7.5.1 Technological Innovation in PCR Testing to Boost Growth
Table 27 Ivd Contract Manufacturing Market for Molecular Diagnostics, by Country, 2021-2028 (USD Million)
7.6 Hematology
7.6.1 Rising Adoption of Automated Hematology Analyzers to Drive Market
Table 28 Ivd Contract Manufacturing Market for Hematology, by Country, 2021-2028 (USD Million)
7.7 Microbiology
7.7.1 Rising Prevalence of Microbial Infections to Drive Market
Table 29 Ivd Contract Manufacturing Market for Microbiology, by Country, 2021-2028 (USD Million)
7.8 Coagulation & Hemostasis
7.8.1 Growing Use of Anticoagulation Therapy in Surgical Procedures to Drive Market
Table 30 Ivd Contract Manufacturing Market for Coagulation & Hemostasis, by Country, 2021-2028 (USD Million)
7.9 Other Technologies
Table 31 Ivd Contract Manufacturing Market for Other Technologies, by Country, 2021-2028 (USD Million)

8 Ivd Contract Manufacturing Market, by Service Type
8.1 Introduction
Table 32 Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
8.2 Manufacturing Services
8.2.1 Manufacturing Services to Hold Largest Market Share Till 2028
Table 33 Manufacturing Services Market, by Country, 2021-2028 (USD Million)
8.3 Assay Development
8.3.1 Low-Cost Setup, Efficiency, and High Throughput to Drive Demand for Assay Development
Table 34 Assay Development Services Market, by Country, 2021-2028 (USD Million)
8.4 Other Services
Table 35 Other Services Market, by Country, 2021-2028 (USD Million)

9 Ivd Contract Manufacturing Market, by Region
9.1 Introduction
Figure 37 Ivd Contract Manufacturing Market: Geographic Growth Opportunities
Table 36 Ivd Contract Manufacturing Market, by Region, 2021-2028 (USD Million)
9.2 Asia-Pacific
9.2.1 Asia-Pacific: Recession Impact
Figure 38 Asia-Pacific: Ivd Contract Manufacturing Market Snapshot
Table 37 Asia-Pacific: Ivd Contract Manufacturing Market, by Country, 2021-2028 (USD Million)
Table 38 Asia-Pacific: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 39 Asia-Pacific: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 40 Asia-Pacific: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.2.2 China
9.2.2.1 Low Labor Costs and Rapidly Changing Healthcare Infrastructure to Drive Market
Table 41 China: Key Macroindicators
Table 42 China: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 43 China: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 44 China: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.2.3 Japan
9.2.3.1 Universal Healthcare Reimbursement Policies to Propel Market
Table 45 Japan: Key Macroindicators
Table 46 Japan: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 47 Japan: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 48 Japan: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.2.4 India
9.2.4.1 Rising Contract Manufacturing Capabilities to Support Growth
Table 49 India: Key Macroindicators
Table 50 India: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 51 India: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 52 India: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.2.5 Australia
9.2.5.1 Need for Advanced Medical and Diagnostic Tools to Fuel Growth
Table 53 Australia: Key Macroindicators
Table 54 Australia: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 55 Australia: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 56 Australia: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.2.6 South Korea
9.2.6.1 Rising Spending on Innovative Ivd Technologies to Support Market Growth
Table 57 South Korea: Key Macroindicators
Table 58 South Korea: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 59 South Korea: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 60 South Korea: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.2.7 Rest of Asia-Pacific
Table 61 Rest of Asia-Pacific: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 62 Rest of Asia-Pacific: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 63 Rest of Asia-Pacific: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.3 North America
9.3.1 North America: Recession Impact
Table 64 North America: Ivd Contract Manufacturing Market, by Country, 2021-2028 (USD Million)
Table 65 North America: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 66 North America: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 67 North America: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.3.2 US
9.3.2.1 Increasing In-House Manufacturing Costs to Encourage Shift to Contract Manufacturing
Table 68 US: Key Macroindicators
Table 69 US: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 70 US: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 71 US: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.3.3 Canada
9.3.3.1 Strong Presence of Key Contract Manufacturing Companies to Drive Market
Table 72 Canada: Key Macroindicators
Table 73 Canada: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 74 Canada: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 75 Canada: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.4 Europe
9.4.1 Europe: Recession Impact
Table 76 Europe: Ivd Contract Manufacturing Market, by Country, 2021-2028 (USD Million)
Table 77 Europe: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 78 Europe: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 79 Europe: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.4.2 Germany
9.4.2.1 Germany to Hold Largest Market Share
Table 80 Germany: Key Macroindicators
Table 81 Germany: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 82 Germany: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 83 Germany: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.4.3 France
9.4.3.1 Increasing Government Pressure to Reduce Healthcare Costs and Budgetary Constraints
Table 84 France: Key Macroindicators
Table 85 France: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 86 France: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 87 France: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.4.4 UK
9.4.4.1 Rising Adoption of Genome-based Testing and Increasing Accessibility of Ivd
Table 88 UK: Key Macroindicators
Table 89 UK: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 90 UK: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 91 UK: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.4.5 Italy
9.4.5.1 Rising Incidence of Chronic Illnesses to Drive Market
Table 92 Italy: Key Macroindicators
Table 93 Italy: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 94 Italy: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 95 Italy: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.4.6 Spain
9.4.6.1 Increasing Adoption of Home-Use Medical Devices to Drive Market
Table 96 Spain: Key Macroindicators
Table 97 Spain: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 98 Spain: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 99 Spain: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.4.7 Rest of Europe
Table 100 Rest of Europe: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 101 Rest of Europe: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 102 Rest of Europe: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.5 Latin America
9.5.1 Latin America: Recession Impact
Table 103 Latin America: Ivd Contract Manufacturing Market, by Country, 2021-2028 (USD Million)
Table 104 Latin America: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 105 Latin America: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 106 Latin America: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.5.2 Mexico
9.5.2.1 Mexico to Hold Largest Share of Latin American Market
Table 107 Mexico: Key Macroindicators
Table 108 Mexico: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 109 Mexico: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 110 Mexico: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.5.3 Brazil
9.5.3.1 Favorable Government Initiatives and Willingness to Pay for Better Healthcare to Drive Market
Table 111 Brazil: Key Macroindicators
Table 112 Brazil: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 113 Brazil: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 114 Brazil: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.5.4 Rest of Latin America
Table 115 Rest of Latin America: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 116 Rest of Latin America: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 117 Rest of Latin America: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)
9.6 Middle East & Africa
9.6.1 Growing Healthcare Investments and Infrastructural Improvements to Drive Market
9.6.2 Middle East & Africa: Recession Impact
Table 118 Middle East & Africa: Ivd Contract Manufacturing Market, by Product Type, 2021-2028 (USD Million)
Table 119 Middle East & Africa: Ivd Contract Manufacturing Market, by Service Type, 2021-2028 (USD Million)
Table 120 Middle East & Africa: Ivd Contract Manufacturing Market, by Technology, 2021-2028 (USD Million)

10 Competitive Landscape
10.1 Overview
10.2 Key Strategies Adopted by Players
10.3 Revenue Share Analysis of Top Market Players
Figure 39 Top Market Players Dominate Ivd Contract Manufacturing Market
10.4 Market Share Analysis
Figure 40 Ivd Contract Manufacturing Market Share Analysis, by Key Player, 2022
10.5 Company Evaluation Matrix, 2022
10.5.1 Stars
10.5.2 Emerging Leaders
10.5.3 Pervasive Players
10.5.4 Participants
Figure 41 Ivd Contract Manufacturing Market: Company Evaluation Quadrant (2022)
10.6 Competitive Benchmarking
Table 121 Overall Company Footprint
Table 122 Ompany Footprint Analysis, by Product Type
Table 123 Company Footprint Analysis, by Service Type
Table 124 Company Footprint Analysis, by Region
10.7 Competitive Scenario
10.7.1 Product Launches
Table 125 Product Launches (January 2020-May 2023)
10.7.2 Deals
Table 126 Deals (January 2020-May 2023)
10.7.3 Other Developments
Table 127 Other Developments (January 2020-May 2023)

11 Company Profiles
11.1 Key Players
(Business Overview, Products Offered, Recent Developments, and Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 Jabil Inc.
Table 128 Jabil Inc.: Company Overview
Figure 42 Jabil Inc.: Company Snapshot (2022)
11.1.2 Sanmina Corporation
Table 129 Sanmina Corporation: Company Overview
Figure 43 Sanmina Corporation: Company Snapshot (2022)
11.1.3 Te Connectivity
Table 130 Te Connectivity: Company Overview
Figure 44 Te Connectivity: Company Snapshot (2022)
11.1.4 Celestica, Inc.
Table 131 Celestica, Inc.: Company Overview
Figure 45 Celestica, Inc.: Company Snapshot (2022)
11.1.5 West Pharmaceutical Services, Inc.
Table 132 West Pharmaceuticals Services, Inc.: Company Overview
Figure 46 West Pharmaceutical Services, Inc.: Company Snapshot (2022)
11.1.6 Savyon Diagnostics, Ltd.
Table 133 Savyon Diagnostics, Ltd.: Company Overview
11.1.7 Kmc Systems
Table 134 Kmc Systems: Company Overview
Figure 47 Elbit Systems: Company Snapshot (2022)
11.1.8 Cenogenics Corporation
Table 135 Cenogenics Corporation: Company Overview
11.1.9 Nova Biomedical
Table 136 Nova Biomedical: Company Overview
11.1.10 Cone Bioproducts
Table 137 Core Bioproducts: Company Overview
11.1.11 Invetech
Table 138 Invetech: Company Overview
Figure 48 Fortive: Company Snapshot (2022)
11.1.12 Avioq, Inc.
Table 139 Avioq, Inc.: Company Overview
11.1.13 Meridian Bioscience, Inc.
Table 140 Meridian Bioscience, Inc.: Company Overview
Figure 49 Meridian Bioscience, Inc.: Company Snapshot (2022)
11.1.14 Kimball Electronics, Inc.
Table 141 Kimball Electronics, Inc.: Company Overview
Figure 50 Kimball Electronics, Inc.: Company Snapshot (2022)
11.1.15 Nemera
Table 142 Nemera: Company Overview
11.1.16 Viant Medical Holdings, Inc.
Table 143 Viant Medical Holdings, Inc.: Company Overview
11.1.17 Phillips-Medisize Corporation
Table 144 Phillips-Medisize Corporation: Company Overview
11.1.18 Nolato Gw, Inc.
Table 145 Nolato Gw, Inc.: Company Overview
Figure 51 Nolato Gw, Inc.: Company Snapshot (2022)
11.1.19 Stratec SE
Table 146 Stratec SE: Company Overview
Figure 52 Stratec SE: Company Snapshot (2022)
11.1.20 Thermo Fisher Scientific, Inc.
Table 147 Thermo Fisher Scientific, Inc.: Company Overview
Figure 53 Thermo Fisher Scientific, Inc.: Company Snapshot (2022)
11.1.21 Fujirebio
Table 148 Fujirebio: Company Overview
Figure 54 H.U. Group: Company Snapshot (2022)
11.1.22 Biokit (Werfen)
Table 149 Biokit: Company Overview
Figure 55 Werfen: Company Snapshot (2022)
11.2 Other Companies
11.2.1 Affinity Lifescience
11.2.2 Sekisui
11.2.3 Prestige Diagnostics
*Details on Business Overview, Products Offered, Recent Developments, and Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) Might Not be Captured in Case of Unlisted Companies

12 Appendix
12.1 Discussion Guide

Executive Summary

Companies Mentioned

  • Affinity Lifescience
  • Avioq, Inc.
  • Biokit (Werfen)
  • Celestica, Inc.
  • Cenogenics Corporation
  • Cone Bioproducts
  • Fujirebio
  • Invetech
  • Jabil Inc.
  • Kimball Electronics, Inc.
  • Kmc Systems
  • Meridian Bioscience, Inc.
  • Nemera
  • Nolato Gw, Inc.
  • Nova Biomedical
  • Phillips-Medisize Corporation
  • Prestige Diagnostics
  • Sanmina Corporation
  • Savyon Diagnostics, Ltd.
  • Sekisui
  • Stratec SE
  • Te Connectivity
  • Thermo Fisher Scientific, Inc.
  • Viant Medical Holdings, Inc.
  • West Pharmaceutical Services, Inc.

Table Information